Piper Sandler raises AbbVie stock target to $227, keeps Overweight rating
Piper Sandler adjusted its financial outlook for pharmaceutical giant AbbVie (NYSE:ABBV), which currently commands a market capitalization of $301 billion, citing upcoming charges and anticipated ...
Business Insider6d
Boston Beer downgraded to Neutral from Overweight at Piper Sandler
Piper Sandler downgraded Boston Beer (SAM) to Neutral from Overweight with a price target of $275, down from $370. The firm updated its model for a diminished outlook on Hard Mtn Dew, which was ...
Seeking Alpha26d
Biogen cut to neutral at Piper Sandler on Alzheimer’s headwinds
Piper Sandler downgraded Biogen (NASDAQ:BIIB) to neutral from overweight on Thursday, citing, among other things, the company's challenges in establishing its presence in the market for Alzheimer ...